NO890723L - Fremgangsmaate for fremstilling av terapeutisk aktive 3-alkenyl-1-azabicyklo 3.2.0 hept-2-en-2-karboksylsyrederivater - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive 3-alkenyl-1-azabicyklo 3.2.0 hept-2-en-2-karboksylsyrederivater

Info

Publication number
NO890723L
NO890723L NO89890723A NO890723A NO890723L NO 890723 L NO890723 L NO 890723L NO 89890723 A NO89890723 A NO 89890723A NO 890723 A NO890723 A NO 890723A NO 890723 L NO890723 L NO 890723L
Authority
NO
Norway
Prior art keywords
alkyl
oxo
hydroxy
pyrrolidinyl
compound
Prior art date
Application number
NO89890723A
Other languages
English (en)
Norwegian (no)
Other versions
NO890723D0 (no
Inventor
Masayoshi Murata
Toshiyuki Chiba
Akira Yamada
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO890723D0 publication Critical patent/NO890723D0/no
Publication of NO890723L publication Critical patent/NO890723L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
NO89890723A 1988-02-22 1989-02-21 Fremgangsmaate for fremstilling av terapeutisk aktive 3-alkenyl-1-azabicyklo 3.2.0 hept-2-en-2-karboksylsyrederivater NO890723L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888804058A GB8804058D0 (en) 1988-02-22 1988-02-22 3-alkenyl-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds

Publications (2)

Publication Number Publication Date
NO890723D0 NO890723D0 (no) 1989-02-21
NO890723L true NO890723L (no) 1989-08-23

Family

ID=10632122

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89890723A NO890723L (no) 1988-02-22 1989-02-21 Fremgangsmaate for fremstilling av terapeutisk aktive 3-alkenyl-1-azabicyklo 3.2.0 hept-2-en-2-karboksylsyrederivater

Country Status (18)

Country Link
US (2) US4923857A (hu)
EP (1) EP0330108B1 (hu)
JP (1) JP2748500B2 (hu)
KR (1) KR890013020A (hu)
CN (1) CN1037149A (hu)
AT (1) ATE132150T1 (hu)
AU (1) AU2983889A (hu)
DE (1) DE68925223T2 (hu)
DK (1) DK66789A (hu)
FI (1) FI890689A (hu)
GB (1) GB8804058D0 (hu)
HU (1) HUT49612A (hu)
IE (1) IE890500L (hu)
IL (1) IL89354A0 (hu)
NO (1) NO890723L (hu)
OA (1) OA09039A (hu)
PT (1) PT89769B (hu)
ZA (1) ZA89986B (hu)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2937911A1 (de) * 1978-09-19 1980-03-27 Daikin Ind Ltd Fluor enthaltende phenylbenzoatverbindungen, verfahren zu ihrer herstellung und ihre verwendung
US5102877A (en) * 1989-04-28 1992-04-07 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
US5258509A (en) * 1989-11-21 1993-11-02 Banyu Pharmaceutical Co., Ltd. Process for producing 2-carbon-substituted carbapenem derivatives
EP0430037A3 (en) * 1989-11-21 1992-05-27 Banyu Pharmaceutical Co., Ltd. Process for producing 2-carbon-substituted carbapenem derivatives
EP0465126A3 (en) * 1990-06-29 1992-03-11 Merck & Co. Inc. Carbapenem antibacterial agents
WO1992002521A1 (en) * 1990-07-27 1992-02-20 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
US5189158A (en) * 1991-03-20 1993-02-23 American Cyanamid Company 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them
US5371215A (en) * 1991-03-20 1994-12-06 American Cyanamid Company 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them
US6005138A (en) 1991-09-23 1999-12-21 Florida State University Tricyclic taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
EP1071685A4 (en) * 1998-04-16 2001-07-18 Merck & Co Inc PREPARATION OF INTERMEDIATE PRODUCTS OF TITANIUM CATALYZED CARBAPENEMS
US6395894B2 (en) 1998-04-16 2002-05-28 Philip J. Pye Process for the synthesis of carbapenem intermidiates, and compounds produced
ATE263766T1 (de) 1998-06-17 2004-04-15 Merck & Co Inc Verfahren zur synthese von carbapenem- zwischenprodukten
US6194568B1 (en) 1998-07-13 2001-02-27 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
KR100351660B1 (ko) * 2000-07-14 2002-09-05 한국화학연구원 2-아릴에테닐 카바페넴 유도체 및 그의 제조방법
US7361785B2 (en) * 2002-11-05 2008-04-22 Lead Chemical Co., Ltd. Compound protecting against ultraviolet rays
AU2006275514B2 (en) 2005-07-29 2012-04-05 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
US8053440B2 (en) 2007-02-01 2011-11-08 Resverlogix Corporation Compounds for the prevention and treatment of cardiovascular diseases
CA2711103C (en) 2008-06-26 2016-08-09 Resverlogix Corp. Methods of preparing quinazolinone derivatives
EP2382194B1 (en) 2009-01-08 2014-03-12 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
JP5795304B2 (ja) 2009-03-18 2015-10-14 レスバーロジックス コーポレイション 新規抗炎症剤
KR101892987B1 (ko) 2009-04-22 2018-08-30 리스버로직스 코퍼레이션 신규한 소염제
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
DK2773354T3 (da) 2011-11-01 2019-08-05 Resverlogix Corp Oralformuleringer med øjeblikkelig frigivelse for substituerede quinazolinoner
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
AU2013365926B9 (en) 2012-12-21 2019-01-17 Zenith Epigenetics Ltd. Novel heterocyclic compounds as bromodomain inhibitors
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
KR102662814B1 (ko) 2015-03-13 2024-05-03 리스버로직스 코퍼레이션 보체 관련 질환을 치료하기 위한 조성물 및 치료 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543257A (en) * 1977-10-19 1985-09-24 Merck & Co., Inc. 1-Carba-2-penem-3-carboxylic acid
US4348320A (en) * 1976-11-19 1982-09-07 Merck & Co., Inc. Substituted azetidiones
US4465632A (en) * 1978-10-24 1984-08-14 Merck & Co., Inc. Process for preparing 1-6-and 2-substituted-1-carba-2-penem-3-carboxylic acids
DE2966497D1 (en) * 1978-10-24 1984-01-26 Merck & Co Inc 6-, 1- and 2-substituted-1-carbapen-2-em-3-carboxylic acids, processes for the preparation of such compounds and pharmaceutical composition comprising such compounds
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
US4267188A (en) * 1979-08-09 1981-05-12 Merck & Co., Inc. 5-Substituted-1-carba-pen-2-em-3-carboxylic acid
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
US4729993A (en) * 1984-12-13 1988-03-08 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having an externally alkylated mono- or bicyclic 2-quaternary heteroarylalkyl substituent
CA1282415C (en) * 1985-08-31 1991-04-02 Yasuhiro Kuramoto Azetidin-2-on derivatives and process for production thereof

Also Published As

Publication number Publication date
ATE132150T1 (de) 1996-01-15
DE68925223D1 (de) 1996-02-08
PT89769A (pt) 1989-10-04
KR890013020A (ko) 1989-09-20
PT89769B (pt) 1994-03-31
FI890689A0 (fi) 1989-02-14
CN1037149A (zh) 1989-11-15
JPH021490A (ja) 1990-01-05
IE890500L (en) 1989-08-22
GB8804058D0 (en) 1988-03-23
EP0330108A1 (en) 1989-08-30
IL89354A0 (en) 1989-09-10
NO890723D0 (no) 1989-02-21
US5081237A (en) 1992-01-14
DK66789D0 (da) 1989-02-13
JP2748500B2 (ja) 1998-05-06
OA09039A (fr) 1991-03-31
US4923857A (en) 1990-05-08
ZA89986B (en) 1989-10-25
AU2983889A (en) 1989-08-24
DK66789A (da) 1989-08-23
EP0330108B1 (en) 1995-12-27
HUT49612A (en) 1989-10-30
DE68925223T2 (de) 1996-06-13
FI890689A (fi) 1989-08-23

Similar Documents

Publication Publication Date Title
US5081237A (en) 3-alkenyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
US4925838A (en) 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
EP0394991B1 (en) 1-Azabicyclo(3.2.0)Hept-2-Ene-2-carboxylic acid compounds
EP0343499B1 (en) 3-Pyrrolidinylthio-1-azabicyclo(3,2,0) hept-2-ene-2-carboxylic acid compounds
US4963543A (en) 3-pyrolidinylthio-1-azabicyclo-[3.2.0]hept-2-ene-2-carboxylic acid derivatives and processes for the preparation thereof
NO164980B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemderivater.
US5215983A (en) Carbapenem compounds
US5286721A (en) 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
US5194624A (en) Intermediates for the preparation of compounds of antimicrobial activity
KR970007946B1 (ko) 2-(2-치환된 피롤리딘-4-일)티오-카바페넴 유도체
DE60130916T2 (de) Neue beta-lactamverbindungen und verfahren zu deren herstellung
WO1992002521A1 (en) 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
US5202437A (en) 3-pyrrolidinylthio-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid compounds
WO1993023402A1 (en) 3-azetidinylthio-carbapeneme derivatives, their preparation and use as antimicrobial agents
EP0722447A1 (en) 3-pyrrolidinylthio-carbapenem derivatives and their antimicrobal activity
JPH05239058A (ja) 3−ピロリジニルチオ−1−アザビシクロ[3.2.0ヘプト−2−エン−2−カルボン酸化合物
EP0506982A1 (en) 1-azabicyclo 3.2.0]hept-2-ene-2-carboxylic acid compounds
JPH03115285A (ja) 3―ピロリジニルチオ―1―アザビシクロ[3.2.0]ヘプト―2―エン―2―カルボン酸誘導体
JPH04321688A (ja) 2−(置換ピロリジニルチオ)カルバペネム誘導体
CA1263117A (en) Carbapenems, their production and use
JPH04234886A (ja) 1−アザビシクロ[3.2.0]ヘプト−2−エン−2−カルボン酸化合物
WO1994005667A1 (en) Carbapenem derivatives and processes for preparing the same
JPWO2002044178A1 (ja) 新規β−ラクタム化合物およびその製造法
JPH06116268A (ja) 3−置換オキシ−1−アザビシクロ[3.2.0]ヘプト−2−エン−2−カルボン酸化合物
JPH1160576A (ja) 三環性複素環誘導体